Literature DB >> 16632102

Genotype/phenotype of familial pancreatic cancer.

Randall E Brand1, Henry T Lynch.   

Abstract

It is estimated that 5% to 10% of pancreatic cancer cases are attributable to hereditary factors. We believe that the number of cases that are genetic in etiology are even greater, however, based not on a classic autosomal dominant pattern of inheritance but rather when one takes into account low-penetrant inherited susceptibility factors. There is also a growing recognition that the development of pancreatic cancer in pancreatic cancer-prone families is dependent not only on genetic variables but on nongenetic factors. The aim of this article is to review the challenges in identifying pancreatic cancer-prone families and how environmental factors interact with genetic factors in these families.

Entities:  

Mesh:

Year:  2006        PMID: 16632102     DOI: 10.1016/j.ecl.2006.02.015

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  6 in total

1.  DNA repair gene polymorphisms and risk of pancreatic cancer.

Authors:  Donghui Li; Hideo Suzuki; Bingrong Liu; Jeffrey Morris; Jun Liu; Taro Okazaki; Yanan Li; Ping Chang; James L Abbruzzese
Journal:  Clin Cancer Res       Date:  2009-01-15       Impact factor: 12.531

2.  Family history of diabetes and pancreatic cancer as risk factors for pancreatic cancer: the PACIFIC study.

Authors:  Melissa A Austin; Elena Kuo; Stephen K Van Den Eeden; Margaret T Mandelson; Teresa A Brentnall; Aruna Kamineni; John D Potter
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-08-21       Impact factor: 4.254

3.  Association between the peroxisome proliferator-activated receptor gamma Pro12Ala variant and haplotype and pancreatic cancer in a high-risk cohort of smokers: a pilot study.

Authors:  Megan Dann Fesinmeyer; Janet L Stanford; Teresa A Brentnall; Margaret T Mandelson; Federico M Farin; Sengkeo Srinouanprachanh; Zahra Afsharinejad; Gary E Goodman; Matt J Barnett; Melissa A Austin
Journal:  Pancreas       Date:  2009-08       Impact factor: 3.327

4.  Intake of folate, vitamins B6, B12 and methionine and risk of pancreatic cancer in a large population-based case-control study.

Authors:  Zhihong Gong; Elizabeth A Holly; Paige M Bracci
Journal:  Cancer Causes Control       Date:  2009-05-05       Impact factor: 2.506

5.  Germline MLH1 and MSH2 mutations in Italian pancreatic cancer patients with suspected Lynch syndrome.

Authors:  S Gargiulo; M Torrini; S Ollila; S Nasti; L Pastorino; R Cusano; L Bonelli; L Battistuzzi; L Mastracci; W Bruno; V Savarino; S Sciallero; G Borgonovo; M Nyström; G Bianchi-Scarrà; C Mareni; P Ghiorzo
Journal:  Fam Cancer       Date:  2009       Impact factor: 2.375

Review 6.  Genetic determinants and potential therapeutic targets for pancreatic adenocarcinoma.

Authors:  Robert Reznik; Andrew E Hendifar; Richard Tuli
Journal:  Front Physiol       Date:  2014-03-03       Impact factor: 4.566

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.